By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Iroko Pharmaceuticals 

Philadelphia  Pennsylvania    U.S.A.
Phone: Fax:



Company News
Iroko Pharmaceuticals Receives FDA Approval For VIVLODEX - First Low Dose SoluMatrix Meloxicam For Osteoarthritis Pain 10/23/2015 7:36:09 AM
Iroko Pharmaceuticals Announces Eighth International Licensing Agreement For ZORVOLEX 7/15/2015 10:02:36 AM
Iroko Pharmaceuticals Release: TIVORBEX Now Available In U.S. Pharmacies For The Treatment Of Acute Pain 6/29/2015 10:51:18 AM
Iroko Pharmaceuticals Announces First International Launch Of ZORVOLEX 5/14/2015 11:17:11 AM
Iroko Pharmaceuticals Announces Additional International Licensing Agreement For ZORVOLEX 5/6/2015 11:34:46 AM
Iroko Pharmaceuticals Granted New Patent For ZORVOLEX 4/29/2015 11:02:38 AM
Iroko Pharmaceuticals Appoints New Member To Company’s Board Of Directors 4/1/2015 9:32:03 AM
Iroko Pharmaceuticals Announces Acceptance Of U.S. Filing For Solumatrix Meloxicam In Osteoarthritis Pain 3/12/2015 8:12:58 AM
Iroko Pharmaceuticals Announces International Regulatory Approval For ZORVOLEX® 12/10/2014 7:37:44 AM
Iroko Pharmaceuticals Release: New Long-Term Safety And Quality Of Life Data Reported For ZORVOLEX® In Osteoarthritis Patients 11/17/2014 4:36:48 PM